Certara, Inc. (CERT) stock analysis

CERT · Certara, Inc.

Latest recorded price: USD 11.39

Model-estimated fair value: USD 3.96. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Health Information Services

At $11.39, CERT trades 187.9% above the model's base-case value of $3.96. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $3.13 in the conservative case and $4.89 in the optimistic case, with a valuation confidence score of 75/100. About 71% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 7.7%, free cash flow margin 22.6%, ROIC 1.5%. The model does not flag any risk signals for this company.

Similar companies in Healthcare